Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lkadalayil
    Junior Member
    • Feb 2013
    • 4

    #1

    Dr

    II am interested in tumour-specific exome CNVs and am using VarScan2. I have finished a preliminary analysis but am stuck with the interpretation.

    The output after CBS gives a variable called num.mark.

    • What does marker mean here?
    • Does it have any relationship to the baits in the capture kit? But then VarScan or CBS never asked for any bed files.
    • Alternatively, is CBS comparing with a reference and detecting alternate alleles/SNPs and calling them as markers?

    Any comments will be appreciated
  • Richard Finney
    Senior Member
    • Feb 2009
    • 701

    #2
    the number of probes on the array that are represented in the region

    Comment

    • lkadalayil
      Junior Member
      • Feb 2013
      • 4

      #3
      I am sorry, what is the definition of a probe then? I am a molecular biologist turned statistician. In my dictionary a probe is an oligonucleotide used to hybridise with a piece of DNA to be PCRed or sequenced. How does VarScan/CBS know which such probe was used? It didn't ask for a bed file containing that information.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:35 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...